Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
about
Splicing Regulators and Their Roles in Cancer Biology and TherapyConnecting the speckles: Splicing kinases and their role in tumorigenesis and treatment responsePotential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)Vascular endothelial growth factor-A165b ameliorates outer-retinal barrier and vascular dysfunction in the diabetic retina.Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells.Serine-arginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/β-catenin signalling in NSCLC.Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cellsLOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.Alternative Splicing in CKD.Pharmacology of Modulators of Alternative Splicing.Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells.The crucial role of SRPK1 in TGF-β-induced proliferation and apoptosis in the esophageal squamous cell carcinomas.Modulators of alternative splicing as novel therapeutics in cancer.Enhancer of rudimentary homologue interacts with scaffold attachment factor B at the nuclear matrix to regulate SR protein phosphorylation.G2/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes.Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling.Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment.Post-Translational Modifications and RNA-Binding Proteins.SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform.Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.Expression of SRPK1 in gliomas and its role in glioma cell lines viability.The Critical Role of SRPK1 in EMT of Human Glioblastoma in the Spinal Cord.Role of alternative splicing of VEGF-A in the development of atherosclerosisSRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer
P2860
Q26798158-4B8E4C93-76DB-4379-90CC-8CD95BB4D3A3Q26824298-53FF36FA-FFED-46F1-9BC9-5FD463599342Q28547020-312C2A82-1B67-462F-8C99-5F10DDCA401AQ33742338-A8AA7FC5-D1A0-46BA-870B-10F51DD5B82FQ33914338-15AA6C26-FBA6-4392-8331-BFFC128C1BB9Q36071281-0004E65A-9468-418B-BF94-DA4C03E98159Q36414039-AFD6AB62-D352-48C6-9A98-13C9323AE8CEQ37690728-C4EB60F1-837F-4E0A-A02D-C355220C3D5FQ37705932-FA608C8F-78F3-4E58-8EA8-14025E71EA7CQ38695755-426F6F3D-1B90-497C-BFBC-59E3FC623E6AQ38776406-3A9915BB-AEAB-4F41-80E0-86768D4BFADFQ38793751-F2E50C2C-EEA8-4A41-8C45-E4CBDEBDBD18Q38811803-11760070-3F8C-449E-B52E-6A83255BDC5EQ38861204-53DB6E04-5282-4AF1-8C75-232D4FB06599Q41904460-55199F9C-B2AF-4584-954E-EFCD61BF8860Q46348230-384F2B4B-DC82-490A-B2B8-AB2FC835A1D7Q47129957-B1C60D15-F603-49F0-8C19-9BFF63C0C03BQ47387115-3F5790DF-DB20-4FA1-AA43-6DDCB4C0CD8CQ49519966-6B8AB5EC-DCC7-414A-9358-AEDEFB8F6492Q51306606-092AD3AB-26E9-4CC8-BC56-10C0FB275DE5Q52686217-5E49BD8C-4928-4DA6-8842-3765D131859CQ52717006-05B9FC2E-48FF-41C7-8593-AFE9DAB9C155Q53221473-2F357CD4-7868-49A2-8F61-899022B6B6DFQ55030693-570EA558-39B2-4515-AAFE-0F4B2197DF23Q57467861-E83AFC22-CC2D-4640-ADEE-BBBC43DEA52FQ58767690-C99F3671-977E-464F-AC57-27B34C33801B
P2860
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
@ast
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
@en
type
label
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
@ast
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
@en
prefLabel
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
@ast
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
@en
P2093
P2860
P356
P1476
Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2014.342
P407
P577
2014-07-10T00:00:00Z
P5875
P6179
1035808091